Compositions and methods for wound healing

US10322206B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10322206-B2
Application numberUS-201715472330-A
CountryUS
Kind codeB2
Filing dateMar 29, 2017
Priority dateMar 29, 2016
Publication dateJun 18, 2019
Grant dateJun 18, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates, in part, to sutures which promote wound closure and/or healing. In particular, the present invention provides fibrin microthread sutures that mimic the mechanical behavior of a target tissue thereby reducing, for example, scarring, inflammation, and cell death at the ligature site, including monofilament sutures.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for promoting wound closure and/or healing of a target tissue in a subject, comprising applying a monofilament suture to the target tissue, wherein the monofilament is: a cohesive fibrin-based thread which mimics the stiffness behavior and elasticity of the target tissue and is produced in a buffer solution. 2. The method of claim 1 , wherein the suture exhibits a stiffness of about 5 MPa to about 20 MPa as measured by Young's modulus. 3. The method of claim 1 , wherein the suture is associated with one or more of a substrate or a physiologically acceptable patch, a dressing, a bandage, or a natural or mechanical valve. 4. The method of claim 1 , wherein the target tissue is a soft tissue selected from skin, tendon, ligament, fascia, fibrous tissue, fat, synovial membrane, and muscle, nerve and blood vessel. 5. The method of claim 4 , wherein the soft tissue is skin. 6. The method of claim 1 , wherein the target tissue is hypertrophic or swollen. 7. The method of claim 1 , wherein the wound is a surgical wound. 8. The method of claim 7 , wherein the surgical wound results from aesthetic surgery. 9. The method of claim 7 , wherein the surgical wound results from skin grafting. 10. The method of claim 1 , wherein the wound is a trauma wound. 11. A method for promoting wound closure and/or healing of a target tissue, comprising applying a monofilament suture to the target tissue of a subject, wherein the monofilament is a cohesive fibrin-based thread which mimics the stiffness behavior and elasticity of the target tissue and is produced in a buffer solution, and wherein the subject has not received a standard of care suture. 12. The method of claim 11 , wherein the standard of care suture comprises silk, linen, nylon, polypropylene, polyamide, polyester, catgut, polyglycolic acid, polyglactin 910, poliglecaprone, or polydioxanone. 13. A method for promoting wound closure and/or healing of a target tissue, comprising applying a monofilament suture to the target tissue of a subject, wherein the monofilament is a cohesive fibrin-based thread which mimics the stiffness behavior and elasticity of the target tissue and is produced in a buffer solution, and wherein the subject has not received an adjuvant therapy. 14. The method of claim 13 , wherein the adjuvant therapy is selected from steroid, silicone, vitamin, laser treatment, radiotherapy, pressure dressing, collagen induction therapy, cryotherapy, or dermabrasion. 15. The method of claim 1 , wherein the monofilament suture is not a multifilament fibrin microthread.

Assignees

Inventors

Classifications

  • containing macromolecular materials · CPC title

  • Homopolymers or copolymers of glycolic acid or lactic acid · CPC title

  • for treating wounds, ulcers, burns, scars, keloids, or the like · CPC title

  • A61L17/08Primary

    of animal origin, e.g. catgut, collagen · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10322206B2 cover?
The present invention relates, in part, to sutures which promote wound closure and/or healing. In particular, the present invention provides fibrin microthread sutures that mimic the mechanical behavior of a target tissue thereby reducing, for example, scarring, inflammation, and cell death at the ligature site, including monofilament sutures.
Who is the assignee on this patent?
Pins George, Gaudette Glenn, Collette Adam, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61L17/08. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).